• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Dr. Reddy's Laboratories Ltd.
    02 Jul 2025
    US FDA Observation
    1310.40
    0.74%
    Dr Reddy's expects US sales dip in FY26, aims for resilience via scale-up
    Business Standard
    With increased US competition from FY26, DRL plans portfolio shifts, inorganic growth, cost control and global expansion to manage profit and revenue impact
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
    Dr Reddy's preparing for challenges in the US Market in Q4
    Business Line | 02 Jul 2025
    logo
    Sigachi Industries Ltd.
    02 Jul 2025
    Dividend
    43.95
    0.21%
    40 staffers killed in blast at Telangana plant: Sigachi Industries
    Business Line
    Operations at the plant to remain suspended for approximately 90 days
    Copy LinkShare onShare on Share on Share on
    Sigachi Industries Ltd. is trading at high day volume of 129.3M.
    Telangana plant explosion: Sigachi used outdated machinery, says FIR
    Business Standard | 02 Jul 2025 6 more
    India factory fire death toll at 40, over 33 injured: Sigachi Industries
    Business Standard | 02 Jul 2025
    Sigachi Industries Shares Slump Nearly 11% Extending Decline To Third Day
    NDTV Profit | 02 Jul 2025
    Sigachi Industries Telangana Factory Blast: Plant Unit Has No NoC From Fire Department
    NDTV Profit | 02 Jul 2025
    Debris clearance almost over, Sigachi unit has no NoC from Fire Department
    Business Line | 02 Jul 2025
    How blast at Sigachi Industries' Hyd Plant leaves many unanswered questions?
    Business Line | 01 Jul 2025
    Govt, Sigachi to pay 1 cr compensation to blast victims: Telangana CM
    Business Standard | 01 Jul 2025
    logo
    AstraZeneca Pharma India Ltd.
    02 Jul 2025
    9016.50
    0.08%
    AstraZeneca Pharma pops 4% on CDSCO nod to import Durvalumab solution
    Business Standard
    AstraZeneca Pharma shares rose after the company received regulatory approval to expand the use of its cancer drug Imfinzi (Durvalumab) in India.
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading above all available SMAs
    AstraZeneca considers moving its stock market listing to US: Report
    Business Standard | 01 Jul 2025
    logo
    Biocon Ltd.
    02 Jul 2025
    360.20
    0.54%
    Biocon climbs 3% on plans to file approvals for generic weight-loss drug
    Business Standard
    Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of Novo Nordisk A/S's Ozempic and Wegovy
    Copy LinkShare onShare on Share on Share on
    Institutional Investors have increased holdings from 21.40% to 28.87% in Jun 2025 qtr.
    Biocon aims to lead copycat Wegovy sales in Canada from next year
    Business Line | 02 Jul 2025 1 more
    Biocon eyes early lead in generic Wegovy, Ozempic sales in Canada from 2026
    Business Standard | 02 Jul 2025
    logo
    Lupin Ltd.
    01 Jul 2025
    2051.80
    0.28%
    Lupin carves out consumer healthcare biz into wholly owned subsidiary
    Business Standard
    The carve-out will be effective from 1 July 2025, according to the company's regulatory filing on the exchanges.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. has an average target of 2326.00 from 8 brokers.
    Drugmaker Lupin creates a separate entity for its consumer healthcare business
    Business Line | 01 Jul 2025 1 more
    Lupin To Spin Off Healthcare Division
    NDTV Profit | 01 Jul 2025
    logo
    Sigachi Industries Ltd.
    01 Jul 2025
    Dividend
    43.95
    0.21%
    T'gana govt slams Sigachi industries management's absence post deadly blast
    Business Standard
    The Telangana government on Tuesday gave a dressing down to the management of Sigachi Industries Ltd for its absence following a factory blast that claimed 35 lives in this district. Chief Minister A Revanth Reddy accompanied by Ministers Sridhar Babu, Damodara Raja Narasimha, G Vivek and P Rsinivasa Reddy visited the factory blast site and reviewed the situation with senior officials. The CM sought a comprehensive report on the incident, including details of past similar occurrences and preventive measures taken. The fatal blast and fire accident at a plant belonging to Sigachi on Monday left 35 dead and an almost equal number injured. Replying to the Chief Minister's query, a company official said the Founder and Executive Chairman of Sigachi was here on Monday. Reddy also pressed the company for an action plan regarding the compensation to the victims. Major accident has taken place. He (senior management) has to come. He has to visit the deceased person's families. You can no
    Copy LinkShare onShare on Share on Share on
    Sigachi Industries Ltd. has gained 43.30% in the last 1 Month
    Sigachi Industries shares drop 18% in two days after fatal accident
    Business Standard | 01 Jul 2025 9 more
    Telangana Pharma Sigachi Factory Blast Live: Death toll climbs to 37, rescue ops continue, Sigachi Industries in focus
    Business Line | 01 Jul 2025
    Sigachi Industries Share Price Extends Loss After Reactor Blast
    NDTV Profit | 01 Jul 2025
    Telangana pharma plant blast toll rises to 34; rescue op underway: Official
    Business Standard | 01 Jul 2025
    Sigachi plant blast: Death toll climbs to 37
    Business Line | 01 Jul 2025
    Sigachi Industries Blast: Officials Say Six Bodies Need DNA Profiling For Identification
    NDTV Profit | 01 Jul 2025
    Sigachi Industries stock tanks 14% after deadly explosion at Telangana unit
    Business Standard | 30 Jun 2025
    Sigachi Industries Reactor Blast In Telangana: 8 Dead, Several Injured In Suspected Explosion, Says Police
    NDTV Profit | 30 Jun 2025
    Sigachi Industries Shares Plunge After Reactor Blast In Telangana
    NDTV Profit | 30 Jun 2025
    Over a dozen injured in a blast at Sigachi Industries' Hyderabad plant
    Business Line | 30 Jun 2025
    logo
    Torrent Pharmaceuticals Ltd.
    01 Jul 2025
    3535.50
    0.11%
    Torrent Pharma Target Price Hiked By BofA On Likely Margin Synergies After JB Deal
    Torrent Pharma Target Price Hiked By BofA On Likely Margin Synergies After JB Deal
    NDTV Profit
    BofA's new target for Torrent Pharma stock implies a return potential of 2.7% over the previous close.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 913 to 923 in Jun 2025 qtr.
    Torrent Pharma said to get $2.3 billion credit line for JB buy
    Business Line | 30 Jun 2025 5 more
    Torrent Pharma to acquire controlling stake in JB Chem and Pharma
    Business Line | 30 Jun 2025
    Torrent Pharma share pops 4% on 25,689-cr JB Chem deal; analysts cautious
    Business Standard | 30 Jun 2025
    Torrent Pharma's JB Acquisition Boosts India Portfolio, Fuels CDMO Expansion, Say Analysts
    NDTV Profit | 30 Jun 2025
    Torrent Pharma to acquire JB Pharma from KKR at 25,689 cr valuation
    Business Standard | 29 Jun 2025
    Torrent Pharma To Acquire Controlling Stake In JB Pharma From KKR For Rs 25,689 Crore
    NDTV Profit | 29 Jun 2025
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    30 Jun 2025
    Insider Trades
    1683.80
    0.26%
    Brokerages positive on medium-term prospects of Torrent-JB Chemicals merger
    Business Standard
    Despite steep premium and short-term earnings dilution, analysts expect Torrent Pharma's acquisition of JB Chemicals to be value accretive in the medium term
    Copy LinkShare onShare on Share on Share on
    J B Chemicals & Pharmaceuticals Ltd.'s price crossed below 50Day SMA today
    Foreign banks offer Torrent 20,000 cr credit line for JB Chemicals buyout
    Business Standard | 30 Jun 2025 6 more
    KKR's exit from JB Chemicals cements its healthcare track record
    Business Standard | 30 Jun 2025
    For one of India's older drugmakers, JB Chem will cease to exist in its present avatar, post merger
    Business Line | 30 Jun 2025
    JB Chemicals Share Price Dips After Torrent Pharmaceuticals Acquisition Announcement
    NDTV Profit | 30 Jun 2025
    JB Chemicals & Torrent Pharma Share Price Live: Torrent to buy KKR's stake in JB Chemicals for 25,689 …
    Business Line | 30 Jun 2025
    Torrent Pharma JB Chemicals Acquisition: What Should JB Chemicals Shareholders Do?
    NDTV Profit | 30 Jun 2025
    Torrent Pharma to acquire controlling stake in JB Chemicals & Pharmaceuticals from KKR for 19,480 crore
    Business Line | 29 Jun 2025
    logo
    Alembic Pharmaceuticals Ltd.
    30 Jun 2025
    971.10
    0.10%
    Alembic Pharma gets USFDA nod for generic cancer treatment injection
    Business Standard
    Alembic Pharmaceuticals on Monday said it has received the final approval from the US health regulator for its generic Doxorubicin Hydrochloride Liposome injection in different types of cancer. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) is for Doxorubicin Hydrochloride Liposome injection of strengths 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials, Alembic Pharmaceuticals said in a statement. The approved ANDA is therapeutically equivalent to the reference-listed drug product (RLD), Doxil Liposome Injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL), of Baxter Healthcare Corporation, it added. Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of ovarian Cancer, AIDS-Related Kaposi's sarcoma, and multiple myeloma, the company said. Citing IQVIA data, Alembic said Doxorubicin Hydrochloride Liposome injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2mg/mL) single-dose...
    Copy LinkShare onShare on Share on Share on
    Alembic Pharmaceuticals Ltd.'s price crossed above 50Day SMA today
    Alembic Pharmaceuticals gets USFDA nod for generic cancer treatment injection
    Business Line | 30 Jun 2025 2 more
    Why is Alembic Pharmaceuticals' share in demand today? Key details here
    Business Standard | 30 Jun 2025
    Alembic Pharma Shares Surge After USFDA Nod For New Ovarian Cancer Drug
    NDTV Profit | 30 Jun 2025
    logo
    Laurus Labs Ltd.
    30 Jun 2025
    894.85
    -0.02%
    Laurus Labs nears record high after 4 years, zooms 84% from 52-week low
    Business Standard
    Laurus Labs management sees a clear pathway for further margin expansion as the company continue delivering on mid-late phase projects, ramping up new assets, and better asset utilisation.
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. has gained 34.24% in the last 3 Months
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • TechD Cybersecurity
    • L T Elevator
    • Euro Pratik Sales
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd